Atrophic Gastritis Treatment Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

Atrophic gastritis is a chronic inflammatory condition of the stomach characterized by the loss of gastric glandular cells. This condition can lead to a variety of complications, including gastric ulcers and an increased risk of gastric cancer. The treatment landscape for atrophic gastritis includes various pharmaceutical products aimed at managing symptoms and underlying causes. This market review provides insights into the atrophic gastritis treatment market, analyzing key aspects such as market size, share, growth trends, and forecasts from 2025 to 2030.

Market Size, Share & Trends Analysis

The global atrophic gastritis treatment market is poised for significant growth over the forecast period. As of 2023, the market size is estimated to be approximately USD 3.5 billion. The increasing prevalence of atrophic gastritis, driven by factors such as aging populations and the rising incidence of Helicobacter pylori infections, is expected to propel market growth.

The market is segmented by product type, including:

Proton Pump Inhibitors (PPIs): These medications reduce gastric acid secretion, alleviating symptoms and promoting healing.
Antibiotics: Utilized primarily for treating H. pylori infections, these drugs are crucial in eradicating the underlying cause of atrophic gastritis.
Stomach-lining Protectors: These agents protect the gastric lining and support recovery.
Vitamin B12: Supplementation is critical due to the potential for malabsorption linked with atrophic gastritis.

Key Players in the Market

The atrophic gastritis treatment market features several prominent players, including:

Takeda Pharmaceutical
AstraZeneca
Teva Pharmaceutical
Abbott
Sandoz
GSK
STADA
Sun Pharma
Laboratrio Teuto
Aurobindo Pharma
Dr. Reddy's Laboratories
NCPC
United Lab
Livzon

These companies are engaged in extensive research and development activities, resulting in innovative treatment options for atrophic gastritis.

Market Segmentation

By Process

The market can be categorized based on the treatment processes, primarily focusing on:

Medications
Natural Remedies

By Application

Distribution channels for atrophic gastritis treatments include:

Hospital Pharmacies
Drug Stores
Online Pharmacies

By End-Use

The end-use segment of the market generally comprises:

Adults
Pediatric Patients

By Region

The geographical segmentation of the market includes:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Market News and Policy Updates

Recent developments in the atrophic gastritis treatment market reflect increasing regulatory support and policy initiatives aimed at enhancing patient access to therapies. Various governments have launched campaigns to educate the public about gastric diseases and the importance of early diagnosis and treatment.

Companies are also focusing on strategic collaborations and partnerships to strengthen their market position. For instance, collaborations between pharmaceutical companies and research institutions have accelerated the development of new and effective treatments. Additionally, there is a growing trend towards personalized medicine, which emphasizes the need for treatments tailored to individual patient profiles.

Segment Forecasts (2025 - 2030)

Looking forward, several factors are expected to influence the atrophic gastritis treatment market:

Increased awareness regarding gastric health and chronic diseases.
Advancements in therapeutic options and delivery mechanisms.
A surge in research focusing on the microbiome and its relation to gastric diseases.
Expected growth of the global healthcare expenditure, particularly in emerging markets.

Based on several indicators, the market is projected to grow at a CAGR of approximately 5.2% from 2025 to 2030, reaching an estimated market size of USD 4.8 billion by the end of the forecast period.

Conclusion

The atrophic gastritis treatment market is on a path of robust growth, driven by an increasing patient population and the evolving landscape of gastroenterological therapies. Key players are expected to leverage emerging trends and innovations to capture market share effectively. With continuous advancements in treatment modalities and a greater focus on patient-centered approaches, the atrophic gastritis treatment market is anticipated to witness significant developments in the coming years.

This product will be delivered within 1-3 business days.

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms

Chapter 3 Preface

3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method

Chapter 4 Market Landscape

4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

Chapter 5 Market Trend Analysis

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

Chapter 6 Industry Chain Analysis

6.1 Upstream/Suppliers Analysis
6.2 Atrophic Gastritis Treatment Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

Chapter 7 Latest Market Dynamics

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

Chapter 8 Historical and Forecast Atrophic Gastritis Treatment Market in North America (2020-2030)

8.1 Atrophic Gastritis Treatment Market Size
8.2 Atrophic Gastritis Treatment Market by End Use
8.3 Competition by Players/Suppliers
8.4 Atrophic Gastritis Treatment Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico

Chapter 9 Historical and Forecast Atrophic Gastritis Treatment Market in South America (2020-2030)

9.1 Atrophic Gastritis Treatment Market Size
9.2 Atrophic Gastritis Treatment Market by End Use
9.3 Competition by Players/Suppliers
9.4 Atrophic Gastritis Treatment Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru

Chapter 10 Historical and Forecast Atrophic Gastritis Treatment Market in Asia & Pacific (2020-2030)

10.1 Atrophic Gastritis Treatment Market Size
10.2 Atrophic Gastritis Treatment Market by End Use
10.3 Competition by Players/Suppliers
10.4 Atrophic Gastritis Treatment Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia

Chapter 11 Historical and Forecast Atrophic Gastritis Treatment Market in Europe (2020-2030)

11.1 Atrophic Gastritis Treatment Market Size
11.2 Atrophic Gastritis Treatment Market by End Use
11.3 Competition by Players/Suppliers
11.4 Atrophic Gastritis Treatment Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia

Chapter 12 Historical and Forecast Atrophic Gastritis Treatment Market in MEA (2020-2030)

12.1 Atrophic Gastritis Treatment Market Size
12.2 Atrophic Gastritis Treatment Market by End Use
12.3 Competition by Players/Suppliers
12.4 Atrophic Gastritis Treatment Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey

Chapter 13 Summary For Global Atrophic Gastritis Treatment Market (2020-2025)

13.1 Atrophic Gastritis Treatment Market Size
13.2 Atrophic Gastritis Treatment Market by End Use
13.3 Competition by Players/Suppliers
13.4 Atrophic Gastritis Treatment Market Size by Type

Chapter 14 Global Atrophic Gastritis Treatment Market Forecast (2025-2030)

14.1 Atrophic Gastritis Treatment Market Size Forecast
14.2 Atrophic Gastritis Treatment Application Forecast
14.3 Competition by Players/Suppliers
14.4 Atrophic Gastritis Treatment Type Forecast

Chapter 15 Analysis of Global Key Vendors

15.1 Takeda Pharmaceutical
15.1.1 Company Profile
15.1.2 Main Business and Atrophic Gastritis Treatment Information
15.1.3 SWOT Analysis of Takeda Pharmaceutical
15.1.4 Takeda Pharmaceutical Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.2 AstraZeneca
15.2.1 Company Profile
15.2.2 Main Business and Atrophic Gastritis Treatment Information
15.2.3 SWOT Analysis of AstraZeneca
15.2.4 AstraZeneca Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.3 Teva Pharmaceutical
15.3.1 Company Profile
15.3.2 Main Business and Atrophic Gastritis Treatment Information
15.3.3 SWOT Analysis of Teva Pharmaceutical
15.3.4 Teva Pharmaceutical Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.4 Abbott
15.4.1 Company Profile
15.4.2 Main Business and Atrophic Gastritis Treatment Information
15.4.3 SWOT Analysis of Abbott
15.4.4 Abbott Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.5 Sandoz
15.5.1 Company Profile
15.5.2 Main Business and Atrophic Gastritis Treatment Information
15.5.3 SWOT Analysis of Sandoz
15.5.4 Sandoz Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.6 GSK
15.6.1 Company Profile
15.6.2 Main Business and Atrophic Gastritis Treatment Information
15.6.3 SWOT Analysis of GSK
15.6.4 GSK Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.7 STADA
15.7.1 Company Profile
15.7.2 Main Business and Atrophic Gastritis Treatment Information
15.7.3 SWOT Analysis of STADA
15.7.4 STADA Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.8 Sun Pharma
15.8.1 Company Profile
15.8.2 Main Business and Atrophic Gastritis Treatment Information
15.8.3 SWOT Analysis of Sun Pharma
15.8.4 Sun Pharma Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.9 Laboratório Teuto
15.9.1 Company Profile
15.9.2 Main Business and Atrophic Gastritis Treatment Information
15.9.3 SWOT Analysis of Laboratório Teuto
15.9.4 Laboratório Teuto Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.10 Aurobindo Pharma
15.10.1 Company Profile
15.10.2 Main Business and Atrophic Gastritis Treatment Information
15.10.3 SWOT Analysis of Aurobindo Pharma
15.10.4 Aurobindo Pharma Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.11 Dr. Reddy's Laboratories
15.11.1 Company Profile
15.11.2 Main Business and Atrophic Gastritis Treatment Information
15.11.3 SWOT Analysis of Dr. Reddy's Laboratories
15.11.4 Dr. Reddy's Laboratories Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.12 NCPC
15.12.1 Company Profile
15.12.2 Main Business and Atrophic Gastritis Treatment Information
15.12.3 SWOT Analysis of NCPC
15.12.4 NCPC Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.13 United Lab
15.13.1 Company Profile
15.13.2 Main Business and Atrophic Gastritis Treatment Information
15.13.3 SWOT Analysis of United Lab
15.13.4 United Lab Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.14 Livzon
15.14.1 Company Profile
15.14.2 Main Business and Atrophic Gastritis Treatment Information
15.14.3 SWOT Analysis of Livzon
15.14.4 Livzon Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2020-2025)

List of Tables and Figures

Table Abbreviation and Acronyms
Table Research Scope of Atrophic Gastritis Treatment Report
Table Data Sources of Atrophic Gastritis Treatment Report
Table Major Assumptions of Atrophic Gastritis Treatment Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Atrophic Gastritis Treatment Picture
Table Atrophic Gastritis Treatment Classification
Table Atrophic Gastritis Treatment Applications
Table Drivers of Atrophic Gastritis Treatment Market
Table Restraints of Atrophic Gastritis Treatment Market
Table Opportunities of Atrophic Gastritis Treatment Market
Table Threats of Atrophic Gastritis Treatment Market
Table COVID-19 Impact For Atrophic Gastritis Treatment Market
Table Raw Materials Suppliers
Table Different Production Methods of Atrophic Gastritis Treatment
Table Cost Structure Analysis of Atrophic Gastritis Treatment
Table Key End Users
Table Latest News of Atrophic Gastritis Treatment Market
Table Merger and Acquisition
Table Planned/Future Project of Atrophic Gastritis Treatment Market
Table Policy of Atrophic Gastritis Treatment Market
Table 2020-2030 North America Atrophic Gastritis Treatment Market Size
Figure 2020-2030 North America Atrophic Gastritis Treatment Market Size and CAGR
Table 2020-2030 North America Atrophic Gastritis Treatment Market Size by Application
Table 2020-2025 North America Atrophic Gastritis Treatment Key Players Revenue
Table 2020-2025 North America Atrophic Gastritis Treatment Key Players Market Share
Table 2020-2030 North America Atrophic Gastritis Treatment Market Size by Type
Table 2020-2030 United States Atrophic Gastritis Treatment Market Size
Table 2020-2030 Canada Atrophic Gastritis Treatment Market Size
Table 2020-2030 Mexico Atrophic Gastritis Treatment Market Size
Table 2020-2030 South America Atrophic Gastritis Treatment Market Size
Figure 2020-2030 South America Atrophic Gastritis Treatment Market Size and CAGR
Table 2020-2030 South America Atrophic Gastritis Treatment Market Size by Application
Table 2020-2025 South America Atrophic Gastritis Treatment Key Players Revenue
Table 2020-2025 South America Atrophic Gastritis Treatment Key Players Market Share
Table 2020-2030 South America Atrophic Gastritis Treatment Market Size by Type
Table 2020-2030 Brazil Atrophic Gastritis Treatment Market Size
Table 2020-2030 Argentina Atrophic Gastritis Treatment Market Size
Table 2020-2030 Chile Atrophic Gastritis Treatment Market Size
Table 2020-2030 Peru Atrophic Gastritis Treatment Market Size
Table 2020-2030 Asia & Pacific Atrophic Gastritis Treatment Market Size
Figure 2020-2030 Asia & Pacific Atrophic Gastritis Treatment Market Size and CAGR
Table 2020-2030 Asia & Pacific Atrophic Gastritis Treatment Market Size by Application
Table 2020-2025 Asia & Pacific Atrophic Gastritis Treatment Key Players Revenue
Table 2020-2025 Asia & Pacific Atrophic Gastritis Treatment Key Players Market Share
Table 2020-2030 Asia & Pacific Atrophic Gastritis Treatment Market Size by Type
Table 2020-2030 China Atrophic Gastritis Treatment Market Size
Table 2020-2030 India Atrophic Gastritis Treatment Market Size
Table 2020-2030 Japan Atrophic Gastritis Treatment Market Size
Table 2020-2030 South Korea Atrophic Gastritis Treatment Market Size
Table 2020-2030 Southeast Asia Atrophic Gastritis Treatment Market Size
Table 2020-2030 Australia Atrophic Gastritis Treatment Market Size
Table 2020-2030 Europe Atrophic Gastritis Treatment Market Size
Figure 2020-2030 Europe Atrophic Gastritis Treatment Market Size and CAGR
Table 2020-2030 Europe Atrophic Gastritis Treatment Market Size by Application
Table 2020-2025 Europe Atrophic Gastritis Treatment Key Players Revenue
Table 2020-2025 Europe Atrophic Gastritis Treatment Key Players Market Share
Table 2020-2030 Europe Atrophic Gastritis Treatment Market Size by Type
Table 2020-2030 Germany Atrophic Gastritis Treatment Market Size
Table 2020-2030 France Atrophic Gastritis Treatment Market Size
Table 2020-2030 United Kingdom Atrophic Gastritis Treatment Market Size
Table 2020-2030 Italy Atrophic Gastritis Treatment Market Size
Table 2020-2030 Spain Atrophic Gastritis Treatment Market Size
Table 2020-2030 Belgium Atrophic Gastritis Treatment Market Size
Table 2020-2030 Netherlands Atrophic Gastritis Treatment Market Size
Table 2020-2030 Austria Atrophic Gastritis Treatment Market Size
Table 2020-2030 Poland Atrophic Gastritis Treatment Market Size
Table 2020-2030 Russia Atrophic Gastritis Treatment Market Size
Table 2020-2030 MEA Atrophic Gastritis Treatment Market Size
Figure 2020-2030 MEA Atrophic Gastritis Treatment Market Size and CAGR
Table 2020-2030 MEA Atrophic Gastritis Treatment Market Size by Application
Table 2020-2025 MEA Atrophic Gastritis Treatment Key Players Revenue
Table 2020-2025 MEA Atrophic Gastritis Treatment Key Players Market Share
Table 2020-2030 MEA Atrophic Gastritis Treatment Market Size by Type
Table 2020-2030 Egypt Atrophic Gastritis Treatment Market Size
Table 2020-2030 Israel Atrophic Gastritis Treatment Market Size
Table 2020-2030 South Africa Atrophic Gastritis Treatment Market Size
Table 2020-2030 Gulf Cooperation Council Countries Atrophic Gastritis Treatment Market Size
Table 2020-2030 Turkey Atrophic Gastritis Treatment Market Size
Table 2020-2025 Global Atrophic Gastritis Treatment Market Size by Region
Table 2020-2025 Global Atrophic Gastritis Treatment Market Size Share by Region
Table 2020-2025 Global Atrophic Gastritis Treatment Market Size by Application
Table 2020-2025 Global Atrophic Gastritis Treatment Market Share by Application
Table 2020-2025 Global Atrophic Gastritis Treatment Key Vendors Revenue
Figure 2020-2025 Global Atrophic Gastritis Treatment Market Size and Growth Rate
Table 2020-2025 Global Atrophic Gastritis Treatment Key Vendors Market Share
Table 2020-2025 Global Atrophic Gastritis Treatment Market Size by Type
Table 2020-2025 Global Atrophic Gastritis Treatment Market Share by Type
Table 2025-2030 Global Atrophic Gastritis Treatment Market Size by Region
Table 2025-2030 Global Atrophic Gastritis Treatment Market Size Share by Region
Table 2025-2030 Global Atrophic Gastritis Treatment Market Size by Application
Table 2025-2030 Global Atrophic Gastritis Treatment Market Share by Application
Table 2025-2030 Global Atrophic Gastritis Treatment Key Vendors Revenue
Figure 2025-2030 Global Atrophic Gastritis Treatment Market Size and Growth Rate
Table 2025-2030 Global Atrophic Gastritis Treatment Key Vendors Market Share
Table 2025-2030 Global Atrophic Gastritis Treatment Market Size by Type
Table 2025-2030 Atrophic Gastritis Treatment Global Market Share by Type

Companies Mentioned

Takeda Pharmaceutical
AstraZeneca
Teva Pharmaceutical
Abbott
Sandoz
GSK
STADA
Sun Pharma
Laboratório Teuto
Aurobindo Pharma
Dr. Reddy's Laboratories
NCPC
United Lab
Livzon

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3500EUR$3,733USD£3,059GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4500EUR$4,800USD£3,933GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€5500EUR$5,866USD£4,807GBP

Market Size, Share & Trends Analysis

Key Players in the Market

Market Segmentation

By Process

By Application

By End-Use

By Region

Market News and Policy Updates

Segment Forecasts (2025 - 2030)

Conclusion

Table of Contents

Companies Mentioned

Related Topics

Related Reports

Autoimmune Gastritis - Pipeline Insight, 2024

Gastritis - Pipeline Insight, 2024

Gastritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

Peptic Ulcer Drugs Market Report and Forecast 2024-2032

Peptic Ulcer Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)